阿达木单抗成功用于治疗溃疡性结肠炎结肠切除术后的坏疽性脓皮病、痤疮和化脓性汗腺炎（PASH综合征）。 - Suppr

Suppr

超能文献

Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis.

作者信息

Murphy Bryan, Morrison Graham, Podmore Pat

机构信息

Altnagelvin Area Hospital, Glenshane Road, Londonderry, BT47 6SB, Northern Ireland,

出版信息

Int J Colorectal Dis. 2015 Aug;30(8):1139-40. doi: 10.1007/s00384-014-2110-9. Epub 2015 Jan 7.

DOI:10.1007/s00384-014-2110-9

PMID:25564349

Abstract

摘要

相似文献

Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis.阿达木单抗成功用于治疗溃疡性结肠炎结肠切除术后的坏疽性脓皮病、痤疮和化脓性汗腺炎（PASH综合征）。

Int J Colorectal Dis. 2015 Aug;30(8):1139-40. doi: 10.1007/s00384-014-2110-9. Epub 2015 Jan 7.

Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.阿达木单抗成功治疗终末期肾病中的坏疽性脓皮病、痤疮和化脓性汗腺炎综合征。

Dermatol Online J. 2017 Dec 15;23(12):13030/qt82d4m2zw.

Pyoderma gangrenosum, acne, hidradenitis suppurativa syndrome associated with type 1 diabetes mellitus treated with adalimumab.用阿达木单抗治疗的与1型糖尿病相关的坏疽性脓皮病、痤疮、化脓性汗腺炎综合征。

G Ital Dermatol Venereol. 2019 Apr;154(2):218-220. doi: 10.23736/S0392-0488.18.05716-4. Epub 2018 Jan 24.

Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.与化脓性汗腺炎和/或痤疮相关的自身炎症性综合征。

Int J Dermatol. 2017 Aug;56(8):811-818. doi: 10.1111/ijd.13603. Epub 2017 Mar 27.

Tumor Necrosis Factor Antagonists in the Treatment of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Syndrome.肿瘤坏死因子拮抗剂在坏疽性脓皮病、痤疮和化脓性汗腺炎（PASH）综合征治疗中的应用

Acta Dermatovenerol Croat. 2018 Jun;26(2):173-178.

Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.坏疽性脓皮病、聚合性痤疮、化脓性汗腺炎和中轴型脊柱关节炎：抗肿瘤坏死因子 α 治疗的疗效。

J Clin Rheumatol. 2012 Dec;18(8):413-5. doi: 10.1097/RHU.0b013e318278b84c.

Treatment of pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) with weight-based anakinra dosing in a Hepatitis B carrier.在一名乙型肝炎携带者中使用基于体重的阿那白滞素剂量治疗坏疽性脓皮病、痤疮、化脓性汗腺炎（PASH）。

Int J Dermatol. 2017 Jun;56(6):e128-e129. doi: 10.1111/ijd.13528. Epub 2017 Feb 27.

Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients.4 例应用靶向抗生素治疗难治性坏疽性脓皮病、重度痤疮和化脓性汗腺炎（PASH）综合征患者的缓解情况。

J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S66-9. doi: 10.1016/j.jaad.2015.07.040.

Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.通过在治疗方案中添加米诺环素和柳氮磺胺吡啶，与囊肿性痤疮和化脓性汗腺炎相关的坏疽性脓皮病得到了控制。

Cutis. 1996 May;57(5):315-9.

Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.成功使用英夫利昔单抗、环孢素和氨苯砜治疗 PAS 综合征。

J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2243-7. doi: 10.1111/jdv.12765. Epub 2014 Oct 28.

引用本文的文献

Unravelling the Link Between Hidradenitis Suppurativa and Inflammatory Bowel Disease: A Literature Review.揭开化脓性汗腺炎与炎症性肠病之间的联系：一项文献综述

Biomedicines. 2025 Jul 27;13(8):1833. doi: 10.3390/biomedicines13081833.

Management of Hidradenitis Suppurativa in Special Populations: A Narrative Review.特殊人群化脓性汗腺炎的管理：一项叙述性综述

Dermatol Ther (Heidelb). 2025 Jun 20. doi: 10.1007/s13555-025-01457-4.

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience.阿达木单抗、优特克单抗和司库奇尤单抗治疗化脓性汗腺炎：真实世界经验综述

Clin Cosmet Investig Dermatol. 2023 Jan 19;16:135-148. doi: 10.2147/CCID.S391356. eCollection 2023.

Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review.坏疽性脓皮病、痤疮和化脓性汗腺炎综合征：一例报告及文献综述

Front Med (Lausanne). 2022 Mar 24;9:856786. doi: 10.3389/fmed.2022.856786. eCollection 2022.

Ancient friends, revisited: Systematic review and case report of pyoderma gangrenosum-associated autoinflammatory syndromes.重温旧友：坏疽性脓皮病相关自身炎症性综合征的系统评价与病例报告

J Transl Autoimmun. 2020 Nov 20;3:100071. doi: 10.1016/j.jtauto.2020.100071. eCollection 2020.

PsAPASH: a rare and recent autoinflammatory syndrome associated with hidradenitis suppurativa.化脓性汗腺炎相关的罕见新型自身炎症综合征（PsAPASH）

An Bras Dermatol. 2020 Mar-Apr;95(2):203-206. doi: 10.1016/j.abd.2019.02.012. Epub 2020 Jan 21.

Systematic review of immunomodulatory therapies for hidradenitis suppurativa.化脓性汗腺炎免疫调节疗法的系统评价

Biologics. 2019 May 13;13:53-78. doi: 10.2147/BTT.S199862. eCollection 2019.

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.北美化脓性汗腺炎临床管理指南：美国和加拿大化脓性汗腺炎基金会联合发布：第二部分：局部、皮损内和全身医学治疗。

J Am Acad Dermatol. 2019 Jul;81(1):91-101. doi: 10.1016/j.jaad.2019.02.068. Epub 2019 Mar 11.

Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.坏疽性脓皮病和肿瘤坏死因子-α抑制剂：半系统综述。

Int Wound J. 2019 Apr;16(2):511-521. doi: 10.1111/iwj.13067. Epub 2019 Jan 3.

本文引用的文献

Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery.肠旁路手术后并发坏疽性脓皮病、痤疮和化脓性汗腺炎。

Dermatology. 2012;225(3):215-9. doi: 10.1159/000343602. Epub 2012 Nov 16.

Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome.坏疽性脓皮病、痤疮和化脓性汗腺炎（PASH）——一种不同于 PAPA 综合征的新型自身炎症性综合征。

J Am Acad Dermatol. 2012 Mar;66(3):409-15. doi: 10.1016/j.jaad.2010.12.025. Epub 2011 Jul 13.

Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review.化脓性汗腺炎合并坏疽性脓皮病：病例系列及文献综述

Arch Dermatol. 2010 Nov;146(11):1265-70. doi: 10.1001/archdermatol.2010.328.

Non-psoriatic dermatologic uses of monoclonal antibody therapy.单克隆抗体治疗的非银屑病性皮肤学用途。

J Dermatolog Treat. 2009;20(6):319-27. doi: 10.3109/09546630902936778.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验